239
Views
57
CrossRef citations to date
0
Altmetric
Original Research

Effects of the protein corona on liposome–liposome and liposome–cell interactions

, , , , , , & show all
Pages 3049-3063 | Published online: 04 Jul 2016

References

  • SinghRLillardJWNanoparticle-based targeted drug deliveryExp Mol Pathol200986321522319186176
  • LundqvistMNanoparticles: tracking protein corona over timeNat Nanotechnol201381070170224056903
  • TenzerSDocterDKuharevJRapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNat Nanotechnol201381077278124056901
  • LynchIDawsonKAProtein-nanoparticle interactionsNano Today2008314047
  • MirsadeghiSDinarvandRGhahremaniMHProtein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation processNanoscale20157115004501325695421
  • O’ConnellDBombelliFBPitekAMonopoliMCahillDDawsonKACharacterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterialsNanoscale2015737152681527626324751
  • ZanganehSSpitlerRErfanzadehMAlkilanyAMMahmoudiMProtein corona: opportunities and challengesInt J Biochem Cell Biol20167514314726783938
  • CorboCMolinaroRParodiAToledano FurmanNESalvatoreFTasciottiEThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryNanomedicine20161118110026653875
  • SalvatiAPitekASMonopoliMPTransferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surfaceNat Nanotechnol20138213714323334168
  • MirshafieeVMahmoudiMLouKChengJKraftMLProtein corona significantly reduces active targeting yieldChem Commun (Camb)201349252557255923423192
  • QiuYLiuYWangLSurface chemistry and aspect ratio mediated cellular uptake of Au nanorodsBiomaterials201031307606761920656344
  • GeCDuJZhaoLBinding of blood proteins to carbon nanotubes reduces cytotoxicityProc Natl Acad Sci U S A201110841169681697321969544
  • GeCTianJZhaoYChenCZhouRChaiZTowards understanding of nanoparticle–protein coronaArch Toxicol201589451953925637415
  • SahnehFDScoglioCMMonteiro-RiviereNARiviereJEPredicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modelingNanomedicine (Lond)2015101253325032980
  • MilaniSBaldelli BombelliFPitekASDawsonKARädlerJReversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard coronaACS Nano2012632532254122356488
  • LiuWRoseJPlantevinSAuffanMBotteroJ-YVidaudCProtein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?Nanoscale2013541658166823334428
  • KarmaliPPSimbergDInteractions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systemsExpert Opin Drug Deliv20118334335721291354
  • MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
  • MirshafieeVKimRParkSMahmoudiMKraftMLImpact of protein pre-coating on the protein corona composition and nanoparticle cellular uptakeBiomaterials20167529530426513421
  • CaraccioloGPalchettiSColapicchioniVStealth effect of biomolecular corona on nanoparticle uptake by immune cellsLangmuir20153139107641077326378619
  • HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
  • KulkarniSAFengS-SEffects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug deliveryPharm Res201330102512252223314933
  • CaraccioloGThe protein corona effect for targeted drug deliveryBioinspired Biomimetic Nanobiomater2013215457
  • MahonESalvatiABombelliFBLynchIDawsonKADesigning the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”J Control Release2012161216417422516097
  • Van RooijenNvan NieuwmegenRLiposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its ownImmunol Commun1980932432567399568
  • LeeHBlaufoxMBlood volume in the ratJ Nucl Med198526172763965655
  • MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
  • MaugisDContact, Adhesion and Rupture of Elastic Solids130BerlinSpringer Science & Business Media2013
  • CorboCOrrùSGemeiMProtein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicityProteomics201212122045205922623141
  • CaterinoMCorboCImperliniEDifferential proteomic analysis in human cells subjected to ribosomal stressProteomics20131371220122723412928
  • CorboCParodiAEvangelopoulosMProteomic profiling of a biomimetic drug delivery platformCurr Drug Targets201516131540154725382209
  • LiG-ZVissersJPSilvaJCGolickDGorensteinMVGeromanosSJDatabase searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixturesProteomics2009961696171919294629
  • NuutilaJLiliusEMFlow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cellsCytometry A20056529310215825183
  • WalczykDBombelliFBMonopoliMPLynchIDawsonKAWhat the cell “sees” in bionanoscienceJ Am Chem Soc2010132165761576820356039
  • Barrán-BerdónALPozziDCaraccioloGTime evolution of nanoparticle–protein corona in human plasma: relevance for targeted drug deliveryLangmuir201329216485649423631648
  • WolframJSuriKYangYShrinkage of pegylated and non-pegylated liposomes in serumColloids Surf B Biointerfaces201411429430024216620
  • HadjidemetriouMAl-AhmadyZMazzaMCollinsRFDawsonKKostarelosKIn vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesiclesACS Nano2015988142815626135229
  • MiclausTBochenkovVEOgakiRHowardKASutherlandDSSpatial mapping and quantification of soft and hard protein coronas at silver nanocubesNano Lett20141442086209324617413
  • GräfeCWeidnerAvd LüheMIntentional formation of a protein corona on nanoparticles-serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interactionInt J Biochem Cell Biol20167519620226556312
  • NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano–bio interfaceNat Mater20098754355719525947
  • MahmoudiMLynchIEjtehadiMRMonopoliMPBombelliFBLaurentSProtein-nanoparticle interactions: opportunities and challengesChem Rev201111195610563721688848
  • WalkeyCDChanWCUnderstanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChem Soc Rev20124172780279922086677
  • TenzerSDocterDRosfaSNanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysisACS Nano2011597155716721866933
  • LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
  • YanYGauseKTKamphuisMMDifferential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell linesACS Nano2013712109601097024256422
  • MulikRSMonkkonenJJuvonenROMahadikKRParadkarARTransferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosisInt J Pharm20103981–219020320655375
  • RicklinDHajishengallisGYangKLambrisJDComplement: a key system for immune surveillance and homeostasisNat Immunol201011978579720720586
  • JohnsonWJMahlbergFHRothblatGHPhillipsMCCholesterol transport between cells and high-density lipoproteinsBiochim Biophys Acta1991108532732981911862
  • CaoWMMuraoKImachiHA mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cellsCancer Res20046441515152114973113
  • ActonSRigottiALandschulzKTXuSHobbsHHKriegerMIdentification of scavenger receptor SR-BI as a high density lipoprotein receptorScience199627152485185208560269
  • PalchettiSColapicchioniVDigiacomoLThe protein corona of circulating PEGylated liposomesBiochim Biophys Acta20161858218919626607013
  • PozziDCaraccioloGDigiacomoLThe biomolecular corona of nanoparticles in circulating biological mediaNanoscale2015733139581396626222625